1. Yang C, Zhao Y, Wang L, Guo Z, Ma L, Yang R, Wu Y, Li X, Niu J, Chu Q, Fu Y, Li B. De novo pyrimidine biosynthetic complexes support cancer cell proliferation and ferroptosis defence. Nat Cell Biol. 2023 Jun;25(6):836-847. doi: 10.1038/s41556-023-01146-4. Epub 2023 Jun 8. PMID: 37291265.

2. Li L, Wang X, Hu K, Liu X, Qiu L, Bai C, Cui Y, Wang B, Wang Z, Wang H, Cheng R, Hua J, Hai L, Wang M, Liu M, Song Z, Xiao C, Li B. ZNF133 is a potent suppressor in breast carcinogenesis through dampening L1CAM, a driver for tumor progression. Oncogene. 2023 Jun;42(27):2166-2182. doi: 10.1038/s41388-023-02731-5. Epub 2023 May 23. PMID: 37221223.

3. Chu Q, An J, Liu P, Song Y, Zhai X, Yang R, Niu J, Yang C, Li B. Repurposing a tricyclic antidepressant in tumor and metabolism disease treatment through fatty acid uptake inhibition. J Exp Med. 2023 Mar 6;220(3):e20221316. doi: 10.1084/jem.20221316. Epub 2022 Dec 15. PMID: 36520461; PMCID: PMC9757841.

4. Tian Y, Fan Z, Xu L, Cao Y, Chen S, Pan Z, Gao Y, Li H, Zheng S, Ma Y, Duan Z, Zhang X, Ren F. CRISPR/Cas13a-assisted rapid and portable HBV DNA detection for low-level viremia patients. Emerg Microbes Infect. 2023 Dec;12(1):e2177088. doi: 10.1080/22221751.2023.2177088. PMID: 36735916; PMCID: PMC9946317.

5. Chen S, Zhang X, Xu L, Tian Y, Fan Z, Cao Y, Pan Z, Gao Y, Zheng S, Duan Z, Liu M, Ren F. Performance of Hepatitis Delta Virus (HDV) RNA Testing for the Diagnosis of Active HDV Infection: Systematic Review and Meta-analysis. J Clin Transl Hepatol. 2023 Nov 28;11(6):1368-1376. doi: 10.14218/JCTH.2022.00107. Epub 2023 Jun 14. PMID: 37719969; PMCID: PMC10500291.

6. Cao Y, Tian Y, Huang J, Xu L, Fan Z, Pan Z, Chen S, Gao Y, Wei L, Zheng S, Zhang X, Yu Y, Ren F. CRISPR/Cas13-assisted carbapenem-resistant Klebsiella pneumoniae detection. J Microbiol Immunol Infect. 2024 Feb;57(1):118-127. doi: 10.1016/j.jmii.2023.10.010. Epub 2023 Nov 7. PMID: 37963801.

7. Tian Y, Fan Z, Zhang X, Xu L, Cao Y, Pan Z, Mo Y, Gao Y, Zheng S, Huang J, Zou H, Duan Z, Li H, Ren F. CRISPR/Cas13a-Assisted accurate and portable hepatitis D virus RNA detection. Emerg Microbes Infect. 2023 Dec;12(2):2276337. doi: 10.1080/22221751.2023.2276337. Epub 2023 Nov 9. PMID: 37882492; PMCID: PMC10796118.

8. Pan Z, Chen S, Xu L, Gao Y, Cao Y, Fan Z, Tian Y, Zhang X, Duan Z, Ren F. Diagnostic Efficacy of Serological Antibody Detection Tests for Hepatitis Delta Virus: A Systematic Review and Meta-Analysis. Viruses. 2023 Nov 29;15(12):2345. doi: 10.3390/v15122345. PMID: 38140586; PMCID: PMC10747714.

9. Xu X, Xu H, Liu X, Zhang S, Cao Z, Qiu L, Du X, Liu Y, Wang G, Zhang L, Zhang Y, Zhang J. MBOAT7 rs641738 (C>T) is associated with NAFLD progression in men and decreased ASCVD risk in elder Chinese population. Front Endocrinol (Lausanne). 2023 Jun 22;14:1199429. doi: 10.3389/fendo.2023.1199429. PMID: 37424875; PMCID: PMC10324031.

10. Zhao J, Xu X, Wei X, Zhang S, Xu H, Wei X, Zhang Y, Zhang J. SAMM50-rs2073082, -rs738491 and -rs3761472 Interactions Enhancement of Susceptibility to Non-Alcoholic Fatty Liver Disease. Biomedicines. 2023 Aug 29;11(9):2416. doi: 10.3390/biomedicines11092416. PMID: 37760857; PMCID: PMC10525902.

11. Gou Y, Wang L, Zhao J, Xu X, Xu H, Xie F, Wang Y, Feng Y, Zhang J, Zhang Y. PNPLA3-I148M Variant Promotes the Progression of Liver Fibrosis by Inducing Mitochondrial Dysfunction. Int J Mol Sci. 2023 Jun 2;24(11):9681. doi: 10.3390/ijms24119681. PMID: 37298640; PMCID: PMC10253263.

12. Pang Y, Shi R, Chan L, Lu Y, Zhu D, Liu T, Yan M, Wang Y, Wang W. The combination of the HDAC1 inhibitor SAHA and doxorubicin has synergic efficacy in triple negative breast cancer in vivo. Pharmacol Res. 2023 Oct;196:106926. doi: 10.1016/j.phrs.2023.106926. Epub 2023 Sep 15. PMID: 37716547.

13. Wang Y, Yan Y, Huo Y, Pang Y, Chan L, Wang S, Chen D, Lin D, Wang W. mRNA sequencing and CyTOF analysis revealed ASPP2 altered the response patterns of hepatocellular carcinoma HepG2 cells to usnic acid. Naunyn Schmiedebergs Arch Pharmacol. 2023 Aug;396(8):1847-1856. doi: 10.1007/s00210-023-02428-2. Epub 2023 Mar 6. PMID: 36877271.

14. Ya X, Li H, Ge P, Xu Y, Liu Z, Zheng Z, Mou S, Liu C, Zhang Y, Wang R, Zhang Q, Ye X, Wang W, Zhang D, Zhao J. Single-Cell Atlas of Atherosclerosis Patients by Cytof: Circulatory and Local Immune Disorders. Aging Dis. 2024 Feb 1;15(1):245-258. doi: 10.14336/AD.2023.0426-1. PMID: 37307820; PMCID: PMC10796097.

15. Zhu D, Lu Y, Hu B, Pang Y, Liu B, Zhang M, Wang W, Wang Y. Highly-tumor-targeted PAD4 inhibitors with PBA modification inhibit tumors in vivo by specifically inhibiting the PAD4-H3cit-NETs pathway in neutrophils. Eur J Med Chem. 2023 Oct 5;258:115619. doi: 10.1016/j.ejmech.2023.115619. Epub 2023 Jul 3. PMID: 37421890.

16. Ge P, Li H, Ya X, Xu Y, Ma L, He Q, Wang R, Liu Z, Zhang Q, Zhang Y, Wang W, Zhang D, Zhao J. Single-cell atlas reveals different immune environments between stable and vulnerable atherosclerotic plaques. Front Immunol. 2023 Jan 18;13:1085468. doi: 10.3389/fimmu.2022.1085468. PMID: 36741406; PMCID: PMC9889979.

17. Wu HX, Wei FL, Zhang W, Han J, Guo S, Wang Z, Chen DX, Hou W, Hu ZJ. Clinical Evaluation of Metagenomic Next-Generation Sequencing Method for the Diagnosis of Suspected Ascitic Infection in Patients with Liver Cirrhosis in a Clinical Laboratory. Microbiol Spectr. 2023 Feb 14;11(1):e0294622. doi: 10.1128/spectrum.02946-22. Epub 2023 Jan 10. PMID: 36625589; PMCID: PMC9927505.

18. Fu Z, Yang G, Wang T, Gao D, Lin D, Liu X. Comprehensive Analysis of the Sorafenib-Associated Druggable Targets on Differential Gene Expression and ceRNA Network in Hepatocellular Carcinoma. J Environ Pathol Toxicol Oncol. 2023;42(4):47-60. doi: 10.1615/JEnvironPatholToxicolOncol.2023045721. PMID: 37522567.

19. Dong H, Liao Q, Xie B, Qiu YA, Peng Z, Deng J, Xiong J, Lu H, Hao Q, Zhou X. Nucleolar stress promotes and cooperates with ferroptosis to suppress cancer growth. Sci China Life Sci. 2023 Nov;66(11):2684-2687. doi: 10.1007/s11427-023-2386-9. Epub 2023 Aug 11. PMID: 37574526.

20. Wang Y, Wang Q, Yang TW, Yin JM, Wei F, Liu H, Yang PX, Li J, Liu N, Zhu Y, Chen D. Analysis of Immune and Inflammatory Microenvironment Characteristics of Noncancer End-Stage Liver Disease. J Interferon Cytokine Res. 2023 Feb;43(2):86-97. doi: 10.1089/jir.2022.0172. Epub 2023 Feb 7. PMID: 36749162.

21. Wu Z, Wang Y, He L, Jin B, Yao Q, Li G, Wang X, Ma Y. Development of a nomogram for the prediction of acute kidney injury after liver transplantation: a model based on clinical parameters and postoperative cystatin C level. Ann Med. 2023;55(2):2259410. doi: 10.1080/07853890.2023.2259410. Epub 2023 Sep 21. PMID: 37734410; PMCID: PMC10515689.

22. Zhang W, Zhang J, Shi H, Liu F, Yu H, Shi H. Exosome GLUT1 derived from hepatocyte identifies the risk of non-alcoholic steatohepatitis and fibrosis. Hepatol Int. 2023 Oct;17(5):1170-1181. doi: 10.1007/s12072-023-10520-1. Epub 2023 Jun 6. PMID: 37278869.

23. Wu M, Wang Z, Shi X, Zan D, Chen H, Yang S, Ding F, Yang L, Tan P, Ma RZ, Wang J, Ma L, Ma Y, Jin J. TGFβ1-RCN3-TGFBR1 loop facilitates pulmonary fibrosis by orchestrating fibroblast activation. Respir Res. 2023 Sep 14;24(1):222. doi: 10.1186/s12931-023-02533-z. PMID: 37710230; PMCID: PMC10500825.

24. Wang Y, Li J, Wang S, Pang Y, Liu P, Xie B, Dou S, Yang T, Liu X, Shi Y, Chen D. The hepatitis B virus promotes the progression of non-alcoholic fatty liver disease through incomplete autophagy. Free Radic Biol Med. 2023 Aug 1;204:326-336. doi: 10.1016/j.freeradbiomed.2023.05.020. Epub 2023 May 25. PMID: 37244371.

25. Luo S, Chen J, Xu F, Chen H, Li Y, Li W. Dendritic Cell-Derived Exosomes in Cancer Immunotherapy. Pharmaceutics. 2023 Aug 1;15(8):2070. doi: 10.3390/pharmaceutics15082070. PMID: 37631284; PMCID: PMC10457773.

26. 張瑩,劉超楠,時紅林,等. P53凋亡刺激蛋白2介導(dǎo)酒精性肝病脂代謝相關(guān)基因的轉(zhuǎn)錄組學(xué)分析[J]. 首都醫(yī)科大學(xué)學(xué)報,2023,44(1):85-92. DOI:10.3969/j.issn.1006-7795.2023.01.013.

27. 高耀,任鋒,段鐘平. HDV RNA檢測的研究現(xiàn)狀[J]. 臨床肝膽病雜志,2023,39(4):758-765. DOI:10.3969/j.issn.1001-5256.2023.04.004.

28. 侯冰,高玉雪,楊鵬翔,等. 脫氧膽酸對HBV復(fù)制及肝癌細(xì)胞自噬影響的研究[J]. 右江民族醫(yī)學(xué)院學(xué)報,2023,45(4):545-551. DOI:10.3969/j.issn.1001-5817.2023.04.001.

29. 尚小飛,李秀惠. 中藥抗肝纖維化實驗研究進(jìn)展[J]. 臨床肝膽病雜志,2023,39(2):249-259. DOI:10.3969/j.issn.1001-5256.2023.02.001.

30. 時紅波,焦彥,許萍,等. 多種線上授課模式在傳染病教學(xué)中的實施和探討[J]. 中國高等醫(yī)學(xué)教育,2023(1):102-103. DOI:10.3969/j.issn.1002-1701.2023.01.047.

31. 張向穎. 淺談乙型肝炎病毒標(biāo)志物[J]. 肝博士,2023(4):35-36.

32. 王文敬,產(chǎn)柳佳. 松蘿干燥地衣提取物-松蘿酸或能輔助治療肝癌[J]. 肝博士,2023(6):51-52.

33. 張磊,劉超楠,韓秀濤,等. 雷公藤乙素對糖尿病腎病足細(xì)胞損傷自噬作用及免疫代謝的影響[J]. 陜西中醫(yī),2023,44(8):1021-1026. DOI:10.3969/j.issn.1000-7369.2023.08.006.

34. 張瑩,劉芳,時紅林,等. 酒精性肝病患者脂代謝相關(guān)差異蛋白的定量分析[J]. 中華肝臟病雜志,2023,31(3):293-299. DOI:10.3760/cma.j.cn501113-20230310-00100.

35. 時紅波,繆興忠,時紅林,等. 醫(yī)學(xué)研究生科研綜合素質(zhì)與能力的培養(yǎng)[J]. 繼續(xù)醫(yī)學(xué)教育,2023,37(8):141-144. DOI:10.3969/j.issn.1004-6763.2023.08.036.

36. 繆興忠,劉芳,張瑩,等. 新型冠狀病毒感染與糖代謝間的關(guān)系[J]. 國際流行病學(xué)傳染病學(xué)雜志,2023,50(3):215-218. DOI:10.3760/cma.j.cn331340-20230228-00030.

37. 產(chǎn)柳佳,王玉記,鄒新,等. 迷迭香酸調(diào)節(jié)p53/p21信號通路誘導(dǎo)非小細(xì)胞肺癌凋亡的體外研究[J]. 中華中醫(yī)藥雜志,2023,38(4):1849-1852.

38. 霍云飛,寇卜心,柴夢音,等. 體外靶向TP53BP2基因shRNA慢病毒載體的構(gòu)建及功能鑒定[J]. 實用肝臟病雜志,2023,26(2):164-168. DOI:10.3969/j.issn.1672-5069.2023.02.004.

39. 霍云飛,高明慧,豆雙雙,等. 靶向RelA(p65)基因shRNA慢病毒載體構(gòu)建及功能鑒定[J]. 中國臨床新醫(yī)學(xué),2023,16(9):907-912. DOI:10.3969/j.issn.1674-3806.2023.09.07.

40. 蔡玉瑩,殷繼明,寧琪琪,等. LC-MS/MS定量分析小鼠肝組織15種膽汁酸成分研究[J]. 實用肝臟病雜志,2023,26(3):320-323. DOI:10.3969/j.issn.1672-5069.2023.03.005.

41. 李偉華,李傳云. 提升醫(yī)學(xué)科學(xué)學(xué)位碩士研究生科研素養(yǎng)的探討[J]. 基礎(chǔ)醫(yī)學(xué)教育,2023,25(2):163-165. DOI:10.13754/j.issn2095-1450.2023.02.17.

42. 肖俐,羅淑敏,徐芳,等. 不同復(fù)蘇方式對凍存外泌體的影響[J]. 首都醫(yī)科大學(xué)學(xué)報,2023,44(4):639-644. DOI:10.3969/j.issn.1006-7795.2023.04.021.

43. 羅淑敏,徐芳,周童,等. 新型冠狀病毒感染患者外泌體免疫膜蛋白與病情進(jìn)展的相關(guān)性研究[J]. 北京醫(yī)學(xué),2023,45(10):835-840. DOI:10.15932/j.0253-9713.2023.10.001.

44. 李亞菊,郭閃,魏飛力. 花旗松素對轉(zhuǎn)化生長因子β1誘導(dǎo)肝星狀細(xì)胞的激活作用及基因表達(dá)譜分析[J]. 中國肝臟病雜志（電子版）,2023,15(3):34-42. DOI:10.3969/j.issn.1674-7380.2023.03.006.